Cargando…

Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation

BACKGROUND: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including seizures and encephalopathy are poorly documented following renal transplantation. CASE PRESENTATION: We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chegounchi, Marjan, Hanna, Michael G, Neild, Guy H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440850/
https://www.ncbi.nlm.nih.gov/pubmed/16573841
http://dx.doi.org/10.1186/1471-2369-7-7
_version_ 1782127333452283904
author Chegounchi, Marjan
Hanna, Michael G
Neild, Guy H
author_facet Chegounchi, Marjan
Hanna, Michael G
Neild, Guy H
author_sort Chegounchi, Marjan
collection PubMed
description BACKGROUND: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including seizures and encephalopathy are poorly documented following renal transplantation. CASE PRESENTATION: We report a 42 year old man who received a cadaver renal transplant. He received tacrolimus and prednisolone. The course was uneventful for 6 weeks when he became intermittently confused, with unsteady gait and slurred speech. Following a grand mal convulsion he was admitted. He had no focal neurological signs, cerebrospinal fluid was normal; electroencephalogram was consistent with temporal lobe partial epilepsy. The magnetic resonance imaging of brain showed widespread changes with multiple areas of low signal intensity in brain stem and cerebral hemispheres. He was readmitted 3 weeks later after further fits, despite anti-convulsant therapy. He was psychotic with visual hallucinations, and rapidly became obtunded. Although his tacrolimus blood concentration had been kept in the normal range, his symptoms improved dramatically when the tacrolimus was stopped. CONCLUSION: Severe central nervous system toxicity from calcineurin inhibitors has been rarely reported in renal transplantation and we found only one report of tacrolimus-induced toxicity in an adult. We believe the condition is frequently undiagnosed. It is a very important diagnosis not to miss as the remedy is simple and failure may result in unnecessary brain biopsy, as well as irreversible injury.
format Text
id pubmed-1440850
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14408502006-04-20 Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation Chegounchi, Marjan Hanna, Michael G Neild, Guy H BMC Nephrol Case Report BACKGROUND: Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including seizures and encephalopathy are poorly documented following renal transplantation. CASE PRESENTATION: We report a 42 year old man who received a cadaver renal transplant. He received tacrolimus and prednisolone. The course was uneventful for 6 weeks when he became intermittently confused, with unsteady gait and slurred speech. Following a grand mal convulsion he was admitted. He had no focal neurological signs, cerebrospinal fluid was normal; electroencephalogram was consistent with temporal lobe partial epilepsy. The magnetic resonance imaging of brain showed widespread changes with multiple areas of low signal intensity in brain stem and cerebral hemispheres. He was readmitted 3 weeks later after further fits, despite anti-convulsant therapy. He was psychotic with visual hallucinations, and rapidly became obtunded. Although his tacrolimus blood concentration had been kept in the normal range, his symptoms improved dramatically when the tacrolimus was stopped. CONCLUSION: Severe central nervous system toxicity from calcineurin inhibitors has been rarely reported in renal transplantation and we found only one report of tacrolimus-induced toxicity in an adult. We believe the condition is frequently undiagnosed. It is a very important diagnosis not to miss as the remedy is simple and failure may result in unnecessary brain biopsy, as well as irreversible injury. BioMed Central 2006-03-31 /pmc/articles/PMC1440850/ /pubmed/16573841 http://dx.doi.org/10.1186/1471-2369-7-7 Text en Copyright © 2006 Chegounchi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Chegounchi, Marjan
Hanna, Michael G
Neild, Guy H
Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
title Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
title_full Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
title_fullStr Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
title_full_unstemmed Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
title_short Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation
title_sort progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440850/
https://www.ncbi.nlm.nih.gov/pubmed/16573841
http://dx.doi.org/10.1186/1471-2369-7-7
work_keys_str_mv AT chegounchimarjan progressiveneurologicaldiseaseinducedbytacrolimusinarenaltransplantrecipientcasepresentation
AT hannamichaelg progressiveneurologicaldiseaseinducedbytacrolimusinarenaltransplantrecipientcasepresentation
AT neildguyh progressiveneurologicaldiseaseinducedbytacrolimusinarenaltransplantrecipientcasepresentation